K173265 is an FDA 510(k) clearance for the UltraVision 2 Diagnostic Ultrasound System. Classified as System, Imaging, Pulsed Doppler, Ultrasonic within the IYN classification (a category covering pulsed Doppler and ultrasound imaging systems), Class II - Special Controls.
Submitted by Winprobe Corporation (Palm Beach Gardens, US). The FDA issued a Cleared decision on November 7, 2017 after a review of 27 days - a notably fast clearance cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1550 - the FDA radiology and imaging software oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Winprobe Corporation devices